Lectins Identify Glycan Biomarkers on Glioblastoma-Derived Cancer Stem Cells

Glioblastoma (GBM) is a highly aggressive primary brain tumor with a poor prognosis. Despite aggressive therapy with surgery, radiotherapy, and chemotherapy, nearly all patients succumb to disease within 2 years. Several studies have supported the presence of stem-like cells in brain tumor cultures...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Tucker-Burden, Carol, Chappa, Prasanthi, Krishnamoorthy, Malini, Gerwe, Brian A., Scharer, Christopher D., Heimburg-Molinaro, Jamie, Harris, Wayne, Usta, Sümeyra Naz, Eilertson, Carmen D., Hadjipanayis, Constantinos G., Stice, Steven L., Brat, Daniel J., Nash, Rodney J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Mary Ann Liebert, Inc. 2012
Soggetti:
Original Research Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3425159/
https://ncbi.nlm.nih.gov/pubmed/22435486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/scd.2011.0369
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi